Cigna Aims to Broaden Obesity Drug Coverage With Financial Guarantees.

Cigna Group has partnered with obesity drug manufacturers Eli Lilly & Co. and Novo Nordisk A/S to expand coverage for weight-loss medications. The agreements aim to limit the amount that employer-sponsored health plans have to pay for these drugs, which have seen a surge in demand. Cigna's program will cap spending increases for these medications at a maximum of 15% annually, providing employers with financial guarantees and potentially increasing access to these treatments. The company's pharmacy benefits manager, Express Scripts, will assume the risk associated with these guarantees. [Extracted from the article]